The polyporous macrofungus Laetiporus sulphureus, commonly referred to as chicken of the woods, is globally recognised as a highly valued edible product used in traditional medicine. Historically, it was used to treat conditions such as respiratory illnesses, gastric disorders, rheumatism, cancer, and metabolic diseases. This review integrates its ethnomycological studies with data on its bioactive compounds and their pharmacological effects and molecular mechanisms. Recent studies supported the finding that L. sulphureus has notable pharmacological properties because of its diverse and rich composition of polysaccharides, triterpenoids, sesquiterpenoids, phenolics, lectins, and many other bioactives. It exhibits a wide range of pharmacological activities, including antioxidant, antimicrobial, anti-inflammatory, immunomodulatory, and anticancer effects. Though generally exhibiting low cytotoxicity, its consumption as food necessitates heat treatment, and collecting the mushroom from conifers (evergreen trees), particularly yew (Taxus), must be avoided. In spite of thorough evaluations of its phytochemistry and in vitro activity, systematic toxicological investigations, long-term safety data, in vivo and (eventually) clinical validation continue to represent significant research gaps.